Piper Sandler raised the firm’s price target on Patterson-UTI (PTEN) to $9 from $7 and keeps a Neutral rating on the shares. The firm notes the company delivered results ahead of expectations already elevated into the print. For Q1 2026, management expects gross profit to be impacted by $5M-$10M due to the winter freeze.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTEN:
- Patterson-UTI price target raised to $9 from $7 at Citi
- Patterson-UTI price target raised to $8 from $6 at Barclays
- Patterson-UTI Earnings Call Highlights Cash, Caution, Tech
- Patterson-UTI reports average of 94 drilling rigs operating in U.S. in January
- Patterson-UTI price target raised to $11 from $9 at Stifel